Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-10-101799
Filing Date
2010-11-05
Accepted
2010-11-05 17:14:17
Documents
12
Period of Report
2010-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q g24892e10vq.htm 10-Q 1226855
2 EX-10.1 g24892exv10w1.htm EX-10.1 70353
3 EX-31.1 g24892exv31w1.htm EX-31.1 9115
4 EX-31.2 g24892exv31w2.htm EX-31.2 9107
5 EX-32.1 g24892exv32w1.htm EX-32.1 3757
6 EX-32.2 g24892exv32w2.htm EX-32.2 3749
  Complete submission text file 0000950123-10-101799.txt   5506586

Data Files

Seq Description Document Type Size
7 EX-101 INSTANCE DOCUMENT kg-20100930.xml EX-101.INS 974978
8 EX-101 SCHEMA DOCUMENT kg-20100930.xsd EX-101.SCH 15692
9 EX-101 CALCULATION LINKBASE DOCUMENT kg-20100930_cal.xml EX-101.CAL 39786
10 EX-101 LABELS LINKBASE DOCUMENT kg-20100930_lab.xml EX-101.LAB 131965
11 EX-101 PRESENTATION LINKBASE DOCUMENT kg-20100930_pre.xml EX-101.PRE 84599
12 EX-101 DEFINITION LINKBASE DOCUMENT kg-20100930_def.xml EX-101.DEF 15931
Mailing Address 501 FIFTH ST BRISTOL TN 37620
Business Address 501 FIFTH ST BRISTOL TN 37620 4239898000
KING PHARMACEUTICALS INC (Filer) CIK: 0001047699 (see all company filings)

EIN.: 541684963 | State of Incorp.: TN | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15875 | Film No.: 101169646
SIC: 2834 Pharmaceutical Preparations